226 related articles for article (PubMed ID: 17218845)
1. Intestinal surgery in advanced ovarian cancer.
Takahashi O; Tanaka T
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):10-4. PubMed ID: 17218845
[TBL] [Abstract][Full Text] [Related]
2. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
3. The role of bowel surgery with cytoreduction for epithelial ovarian cancer.
Cai HB; Zhou YF; Chen HZ; Hou HY
Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):757-62. PubMed ID: 17889517
[TBL] [Abstract][Full Text] [Related]
4. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
5. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Aletti GD; Dowdy SC; Gostout BS; Jones MB; Stanhope CR; Wilson TO; Podratz KC; Cliby WA
Obstet Gynecol; 2006 Jan; 107(1):77-85. PubMed ID: 16394043
[TBL] [Abstract][Full Text] [Related]
6. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.
Aletti GD; Dowdy SC; Podratz KC; Cliby WA
Am J Obstet Gynecol; 2007 Dec; 197(6):676.e1-7. PubMed ID: 18060979
[TBL] [Abstract][Full Text] [Related]
7. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.
Bristow RE; Peiretti M; Zanagnolo V; Salani R; Giuntoli RL; Maggioni A
Gynecol Oncol; 2008 Jun; 109(3):364-9. PubMed ID: 18396322
[TBL] [Abstract][Full Text] [Related]
8. [Up-date on cytoreductive surgery in the management of advanced ovarian cancer].
Angioli R; Palaia I; Damiani P; Montera R; Benedetti Panici P
Minerva Ginecol; 2006 Dec; 58(6):459-70. PubMed ID: 17108876
[TBL] [Abstract][Full Text] [Related]
9. [Controversies in surgical treatment of advanced ovarian cancer].
Tropé C; Paulsen T; Baekelandt M; Makar A
Tidsskr Nor Laegeforen; 2000 Mar; 120(7):824-30. PubMed ID: 10806907
[TBL] [Abstract][Full Text] [Related]
10. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
Harter P; du Bois A; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Schröder W; Muenstedt K; Schmalfeldt B; Emons G; Pfisterer J; Wollschlaeger K; Meerpohl HG; Breitbach GP; Tanner B; Sehouli J; ;
Ann Surg Oncol; 2006 Dec; 13(12):1702-10. PubMed ID: 17009163
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Du Bois A;
Gynecol Oncol; 2007 Jul; 106(1):69-74. PubMed ID: 17397910
[TBL] [Abstract][Full Text] [Related]
12. Colon resection for ovarian cancer: intraoperative decisions.
Hoffman MS; Zervose E
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S56-65. PubMed ID: 18835022
[TBL] [Abstract][Full Text] [Related]
13. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
[TBL] [Abstract][Full Text] [Related]
14. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
15. Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease.
Chang SJ; Bristow RE
Gynecol Oncol; 2012 May; 125(2):483-92. PubMed ID: 22366151
[TBL] [Abstract][Full Text] [Related]
16. "Optimal" cytoreduction for advanced epithelial ovarian cancer: a commentary.
Eisenkop SM; Spirtos NM; Lin WC
Gynecol Oncol; 2006 Oct; 103(1):329-35. PubMed ID: 16876853
[TBL] [Abstract][Full Text] [Related]
17. Total colectomy as part of primary cytoreductive surgery in advanced Müllerian cancer.
Song YJ; Lim MC; Kang S; Seo SS; Park JW; Choi HS; Park SY
Gynecol Oncol; 2009 Aug; 114(2):183-7. PubMed ID: 19427682
[TBL] [Abstract][Full Text] [Related]
18. Advances in the surgical management of ovarian cancer.
Horowitz NS; Duska LR
J Reprod Med; 2005 Jun; 50(6):454-66. PubMed ID: 16050570
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
20. Role of surgery in ovarian carcinoma.
Fader AN; Rose PG
J Clin Oncol; 2007 Jul; 25(20):2873-83. PubMed ID: 17617518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
